Robert Garland
Investing Profile
Sweet spot: $25M
Range: $2M–$50M
Fund: $6.2B
Sector and stage focus
- Seed: Medical Devices, Pharmaceuticals
- Series B: Medical Devices, Pharmaceuticals
- Series A: Medical Devices, Pharmaceuticals
- general: San Francisco Bay Area
Recent investments by Robert Garland
Robert Garland has 4 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Trevena | Series B | Jul 2010 | $35M |
| Sagimet Biosciences | Series D | Dec 2014 | $29M |
| Cardioxyl Pharmaceuticals | Series A | Dec 2006 | $15M |
| Cleave Therapeutics | Series B | Aug 2016 | $37M |
Frequent co-investors
Robert Garland has co-invested with: Carol Gallagher, Beth Seidenberg.
Is Robert Garland a fit for your round?
Upload your pitch deck and see whether Robert Garland appears in your top 20 matches.
Find investors for your deck